Skip to main content

Table 2 The aberrant expression of p16 INK4a or Bmi1 in molecular subtypes of breast cancer

From: Estrogen receptor α-coupled Bmi1 regulation pathway in breast cancer and its clinical implications

Subtypes p16INK4a Pvalue Bmi1 Pvalue
  - +   - +  
LA 28 0 <0.0001 0 28 <0.0001
LB 22 4 1 25
LHP 8 0 0 8
HP 5 11 7 9
TNBC 2 12 11 3
Total 65 27 19 73
  1. Abbreviations: LA Luminal-A, LB Luminal-B, LHP Luminal-HER2-Positive, HP HER2-Positive (HER2-enriched), TNBC Triple Negative Breast Cancer.
  2. Bold face representing significant data (P<0.05).